WHO R&D Blueprint: Informal Consultation on Prioritization of Candidate Therapeutic Agents for Use in Novel Coronavirus 2019 Infection, Geneva, Switzerland, 24 January 2020 | NLM

Disaster Information Management Research Center | NLM

WHO R&D Blueprint: Informal Consultation on Prioritization of Candidate Therapeutic Agents for Use in Novel Coronavirus 2019 Infection, Geneva, Switzerland, 24 January 2020

01/27/2020 12:00 AM EST

Source: World Health Organization (WHO). Published: 1/27/2020. This 16-page document details the objectives of a consultation held on January 24, 2020, on candidate therapeutic agents for use in novel coronavirus (COVID-19) infection: to outline criteria that could inform the evidence-based selection of therapeutic agents for clinical trials; review and critically appraise the existing evidence regarding different investigational therapeutics agents; and decide on the more promising candidate therapeutics, based on currently available evidence that can be evaluated in humans infected with COVID-19 to reduce mortality and disease progression. (PDF)